Fluorescence Lifetime Imaging Ophthalmoscopy and the Influence of Oral Lutein/zeaxanthin Supplementation on Macular Pigment (FLOS) – A pilot study
Oral lutein (L) and zeaxanthin (Z) supplementation enhances macular pigment optical density (MPOD) and plays a protective role in the development of age-related macular degeneration (AMD). Fluorescence lifetime imaging ophthalmoscopy (FLIO) is a novel in vivo retinal imaging method that has been shown to correlate to classical MPOD measurements and might contribute to a metabolic mapping of the retina in the future. Our aim was to show that oral supplementation of L and Z affects the FLIO signal in a positive way, in patients with AMD.
Source: Clinical Nutrition ESPEN - Category: Nutrition Authors: Damian Jaggi, Yasmin Solberg., Chantal Dysli., Joel Lincke., Oussama Habra., Adrian Wyss., Sebastian Wolf., Martin Zinkernagel. Tags: Original article Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Lutein | Nutrition | Ophthalmoscopy | Opthalmology | Study | Vitamin A | Zeaxanthin